FOXO Technologies Inc. (FOXO)

OTC Markets OTCPK

$0.12+3.91% today

Price as at 1 Oct 2026, 20:01 UTC. Quotes are delayed.

Fundamentals

Valuation and ratings

FOXO Technologies Inc. trades at $0.12. We do not hold enough of the inputs to value this company with the confidence the estimate implies, so we publish no fair value for it rather than a number we would not defend.

About FOXO Technologies Inc.

FOXO Technologies Inc. operates as a healthcare services and technology company in the United States. It operates through three segments: Healthcare, Life Science Services, and Labs. The company offers behavioral health; ancillary, including laboratory, radiology, respiratory, and pharmacy; insurance; epigenetics diagnostics and interpretation; and other services. Its technology enables the adoption of saliva-based health and wellness biomarker solutions for underwriting and risk assessment; and Bioinformatics services that provides data solutions using AI and machine learning for data analysis and processing, and quality checking for academia, healthcare, government, and pharmaceutical research customers. FOXO Technologies Inc. was founded in 2020 and is based in West Palm Beach, Florida.

Industry: Medical Care FacilitiesEmployees: 192HQ: United States

Company profile, industry and headcount are as reported by our data provider and can lag a company's own filings by a reporting period. The annual report is the authority.

Common questions

Where does SteadyShares get its FOXO data?

Fundamentals for FOXO come from company filings and exchange data, as listed on OTC Markets OTCPK; institutional ownership comes from SEC 13F filings. The share price shown was last refreshed on 1 Oct 2026, 20:01 UTC and is delayed. Metrics we do not hold are left out of the page rather than estimated.

The full research page for FOXO, with financial statements, ownership detail, peer comparison and alerts, is free inside the app.

Data from company filings, exchange quotes and SEC EDGAR 13F disclosures. Quotes are delayed. Metrics we do not have are left out rather than estimated. Educational information, not financial advice.